Wick Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wick Capital Partners's LLY Position: Q2 2026 in Review
Wick Capital Partners increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $245K and bringing the position to 891 shares worth $1.07M. The position accounts for 0.16% of the portfolio, ranked #56.
Wick Capital Partners first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Wick Capital Partners held 891 shares of Eli Lilly worth $1.07M as of Q2 2026.
- Wick Capital Partners bought 240 Eli Lilly shares in Q2 2026, an estimated $245K.
- Eli Lilly made up 0.16% of Wick Capital Partners's portfolio in Q2 2026, its #56 holding.
- Wick Capital Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Wick Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.